For this, incorporating genetic markers (e.g., IDH1 mutation, MGMT promoter methylation) with imaging features (e.g., signal intensity, diffusion metrics, perfusion parameters) was proposed, which provided a more accurate and dynamic measurement of tumor heterogeneity (76). The gene discussed is IDH1; the disease is neoplasm.